logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Enuresis

    Medications for Enuresis

    FiltersReset Filters
    3 results

    • imipramine hydrochloride

      (Imipramine Hydrochloride)
      Strides Pharma Science Limited
      Usage: This drug is indicated for the relief of symptoms of depression, particularly effective for endogenous depression. It may also serve as temporary adjunctive therapy for childhood enuresis in children over 6, after excluding organic causes. Treatment effectiveness may diminish with prolonged use.

    • imipramine hydrochloride

      (Imipramine Hydrochloride)
      Leading Pharma, LLC
      Usage: This drug is indicated for relieving symptoms of depression, particularly endogenous depression, and may take 1 to 3 weeks for optimal effects. It is also used as temporary adjunctive therapy for reducing childhood enuresis in children aged 6 and older, after excluding organic causes.

    • imipramine hydrochloride

      (Imipramine Hydrochloride)
      Oxford Pharmaceuticals, LLC
      Usage: The drug is indicated for the relief of depression symptoms, particularly effective in endogenous depression, requiring 1-3 weeks for optimal results. It also serves as temporary adjunctive therapy for childhood enuresis in children aged 6 and older after excluding organic causes. Effectiveness may diminish with prolonged use.